"Operation Naloxone: Interactive Harm Reduction Education for Health Professions Students"

Presenter

Dr. Lucas Hill, PharmD
Lucas G. Hill graduated from the University of Missouri-Kansas City School of Pharmacy and completed a combined family medicine residency and faculty development fellowship in the University of Pittsburgh Medical Center St. Margaret Department of Family Medicine. He is now a clinical assistant professor at The University of Texas at Austin (UT) College of Pharmacy. Dr. Hill is the director and principal investigator of Operation Naloxone, an interprofessional opioid overdose prevention program funded through the Texas Targeted Opioid Response. His research is focused on clinician-community collaborations to address substance use disorders through evidence-based treatment and harm reduction strategies. Dr. Hill coordinates the first year of the UT Foundations for Interprofessional Collaborative Practice curriculum and serves as lead instructor for a module that trains students from pharmacy, medicine, nursing, and social work to provide team-based care for patients with addiction. He provides an additional 16 hours of addiction-related instruction in the required pharmacy curriculum and precepts both the overdose prevention introductory pharmacy practice experience and the addiction medicine advanced pharmacy practice experience. Dr. Hill currently serves as chair-elect of the American Association of Colleges of Pharmacy Substance Use Disorder Special Interest Group. He is also faculty advisor for the UT Student Pharmacist Recovery Network and co-chair for the UT Opioid Response Consortium. In 2020, Dr. Hill was awarded the American Pharmacists Association Generation Rx Award of Excellence in recognition of his outstanding contributions to addiction-related education.

Disclosure Statement

The University of Minnesota, College of Pharmacy has a conflict of interest policy that requires course faculty to disclose whether they have financial interests or affiliations with organizations with a direct substantial interest in the subject matter of their programs. The following information was received from Dr. Lucas Hill.

Dr. Lucas Hill, PharmD

No relationships to disclose. Dr. Hill does not discuss off-label or investigational uses of commercial products.

 

Continuing Education credits will be available soon